-
1
-
-
0025886953
-
Adoptive T cell therapy of tumors: Mechanisms operative in the recognition and elimination of tumor cells
-
Greenberg, P.D. 1991. Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv. Immunol. 49:281-355.
-
(1991)
Adv. Immunol.
, vol.49
, pp. 281-355
-
-
Greenberg, P.D.1
-
2
-
-
0026510329
-
Tumour eradication by adoptive transfer of cytotoxic T lymphocytes
-
Melief, C.J. 1992. Tumour eradication by adoptive transfer of cytotoxic T lymphocytes. Adv. Cancer Res. 58:143-175.
-
(1992)
Adv. Cancer Res.
, vol.58
, pp. 143-175
-
-
Melief, C.J.1
-
3
-
-
0028989971
-
Genes coding for tumour antigens recognized by cytolytic T lymphocytes
-
van Pel, A., P. van der Bruggen, P.C. Coulie, V.G. Brichard, B. Lethe, B. van den Eynde, C. Uyttenhove, J.C. Renauld, and T. Boon. 1995. Genes coding for tumour antigens recognized by cytolytic T lymphocytes. Immunol. Rev. 145:229-250.
-
(1995)
Immunol. Rev.
, vol.145
, pp. 229-250
-
-
Van Pel, A.1
Van Der Bruggen, P.2
Coulie, P.C.3
Brichard, V.G.4
Lethe, B.5
Van Den Eynde, B.6
Uyttenhove, C.7
Renauld, J.C.8
Boon, T.9
-
4
-
-
0027078670
-
Costimulation of antitumor immunity by the counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
-
Chen, L., S. Ashe, W.A. Brady, I. Hellström, K.E. Hellström, J.A. Ledbetter, P. McGowan, and P.S. Lindsley. 1992. Costimulation of antitumor immunity by the counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell. 71:1093-1102.
-
(1992)
Cell
, vol.71
, pp. 1093-1102
-
-
Chen, L.1
Ashe, S.2
Brady, W.A.3
Hellström, I.4
Hellström, K.E.5
Ledbetter, J.A.6
McGowan, P.7
Lindsley, P.S.8
-
5
-
-
0028263666
-
+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma
-
+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma. J. Immunol. 153: 421-428.
-
(1994)
J. Immunol.
, vol.153
, pp. 421-428
-
-
Li, Y.1
McGowan, P.2
Hellström, I.3
Hellström, K.E.4
Chen, L.5
-
6
-
-
0029310484
-
Can costimulated tumour immunity be therapeutically efficacious?
-
Hellström, K.E., I. Hellström, and L. Chen. 1995. Can costimulated tumour immunity be therapeutically efficacious? Immunol. Rev. 145:121-145.
-
(1995)
Immunol. Rev.
, vol.145
, pp. 121-145
-
-
Hellström, K.E.1
Hellström, I.2
Chen, L.3
-
7
-
-
0027403299
-
The role of CD28 receptor during T cell responses to antigen
-
Linsley, P.S., and J.A. Ledbetter. 1995. The role of CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191-219.
-
(1995)
Annu. Rev. Immunol.
, vol.11
, pp. 191-219
-
-
Linsley, P.S.1
Ledbetter, J.A.2
-
8
-
-
0020634718
-
Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells
-
Schrier, P.I., R. Bernards, T.M.J. Vaessen, A. Houweling, and A.J. van der Eb. 1983. Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature (Lond.). 305:771-775.
-
(1983)
Nature (Lond.)
, vol.305
, pp. 771-775
-
-
Schrier, P.I.1
Bernards, R.2
Vaessen, T.M.J.3
Houweling, A.4
Van Der Eb, A.J.5
-
9
-
-
0020507874
-
Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity
-
Zijlstra, M., and C.J.M. Melief. 1983. Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity. Nature (Lond.). 305:776-779.
-
(1983)
Nature (Lond.)
, vol.305
, pp. 776-779
-
-
Zijlstra, M.1
Melief, C.J.M.2
-
10
-
-
0006906715
-
Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia
-
Smith, M.E.F., S.G.E. Marsh, J.G. Bodmer, K. Gelsthorpe, and W.F. Bodmer. 1989. Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia. Proc. Natl. Acad. Sci. USA. 86:5557-5561.
-
(1989)
Proc. Natl. Acad. Sci. USA
, vol.86
, pp. 5557-5561
-
-
Smith, M.E.F.1
Marsh, S.G.E.2
Bodmer, J.G.3
Gelsthorpe, K.4
Bodmer, W.F.5
-
11
-
-
0020546609
-
Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than to immunosuppression
-
Uyttenhove, C., J. Maryanski, and T. Boon. 1983. Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than to immunosuppression. J. Exp. Med. 157:1040-1052.
-
(1983)
J. Exp. Med.
, vol.157
, pp. 1040-1052
-
-
Uyttenhove, C.1
Maryanski, J.2
Boon, T.3
-
12
-
-
0022616253
-
Selective rejection of H-2-deficient lymphoma variants suggests alternative immunedefence strategy
-
Karre, K., H.G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immunedefence strategy. Nature (Lond.). 319:675-678.
-
(1986)
Nature (Lond.)
, vol.319
, pp. 675-678
-
-
Karre, K.1
Ljunggren, H.G.2
Piontek, G.3
Kiessling, R.4
-
13
-
-
0029616324
-
Perform dependence of natural killer cell-mediated tumor control in vivo
-
van den Brock, M.F., D. Kägi, R.M. Zinkernagel, and H. Hengartner. 1995. Perform dependence of natural killer cell-mediated tumor control in vivo. Eur. J. Immunol. 25:3514-3516.
-
(1995)
Eur. J. Immunol.
, vol.25
, pp. 3514-3516
-
-
Van Den Brock, M.F.1
Kägi, D.2
Zinkernagel, R.M.3
Hengartner, H.4
-
14
-
-
0028219791
-
Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice
-
Kägi, D., B. Ledermann, K. Bürki, P. Seiler, B. Odermatt, K.J. Olsen, E.R. Podack, R.M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature (Lond.). 369:31-37.
-
(1994)
Nature (Lond.)
, vol.369
, pp. 31-37
-
-
Kägi, D.1
Ledermann, B.2
Bürki, K.3
Seiler, P.4
Odermatt, B.5
Olsen, K.J.6
Podack, E.R.7
Zinkernagel, R.M.8
Hengartner, H.9
-
15
-
-
0028113548
-
Characterization of a granule-independent lytic mechanism used by CTL hybridomas
-
Garner, R., C.D. Helgason, E.A. Atkinson, M.J. Pinkoski, H.L. Ostergaard, O. Sorensen, A. Fu, P.H. Lapchak, A. Rabinovitch, J.E. McElhaney et al. 1994. Characterization of a granule-independent lytic mechanism used by CTL hybridomas. J. Immunol. 153:5413-5421.
-
(1994)
J. Immunol.
, vol.153
, pp. 5413-5421
-
-
Garner, R.1
Helgason, C.D.2
Atkinson, E.A.3
Pinkoski, M.J.4
Ostergaard, H.L.5
Sorensen, O.6
Fu, A.7
Lapchak, P.H.8
Rabinovitch, A.9
McElhaney, J.E.10
-
16
-
-
0001913634
-
The functions and mechanisms of action of cytolytic lymphocytes
-
W.E. Paul, editor. Raven Press Ltd., New York
-
Berke, G. 1993. The functions and mechanisms of action of cytolytic lymphocytes, In Fundamental Immunology. W.E. Paul, editor. Raven Press Ltd., New York. 965-1014.
-
(1993)
Fundamental Immunology
, pp. 965-1014
-
-
Berke, G.1
-
17
-
-
0028990670
-
Lymphocyte-mediated cytotoxicity in vitro and in vivo: Mechanisms and significance
-
Kägi, D., B. Ledermann, K. Bürki, R.M. Zinkernagel, and H. Hengartner. 1995. Lymphocyte-mediated cytotoxicity in vitro and in vivo: mechanisms and significance. Immunol. Rev. 146:95-116.
-
(1995)
Immunol. Rev.
, vol.146
, pp. 95-116
-
-
Kägi, D.1
Ledermann, B.2
Bürki, K.3
Zinkernagel, R.M.4
Hengartner, H.5
-
18
-
-
0028110345
-
Immune function in mice lacking the perform gene
-
Walsh, C.M., M. Matloubian, C.-C. Liu, R. Ueda, C.G. Kurahara, J.L. Christensen, M.T.F. Huang, J.D.E. Young, R. Ahmed, and W.R. Clark. 1994. Immune function in mice lacking the perform gene. Proc. Natl. Acad. Sci. USA. 91: 10854-10858.
-
(1994)
Proc. Natl. Acad. Sci. USA
, vol.91
, pp. 10854-10858
-
-
Walsh, C.M.1
Matloubian, M.2
Liu, C.-C.3
Ueda, R.4
Kurahara, C.G.5
Christensen, J.L.6
Huang, M.T.F.7
Young, J.D.E.8
Ahmed, R.9
Clark, W.R.10
-
19
-
-
0028486130
-
Two distinct pathways of specific killing revealed by perform mutant cytotoxic T lymphocytes
-
Kojima, H., N. Shinohara, S. Hanaoka, Y. Someya-Shirota, Y. Takagaki, H. Ohno, T. Saito, T. Katayama, H. Yagita, K. Okumura et al. 1994. Two distinct pathways of specific killing revealed by perform mutant cytotoxic T lymphocytes. Immunity. 1:357-364.
-
(1994)
Immunity
, vol.1
, pp. 357-364
-
-
Kojima, H.1
Shinohara, N.2
Hanaoka, S.3
Someya-Shirota, Y.4
Takagaki, Y.5
Ohno, H.6
Saito, T.7
Katayama, T.8
Yagita, H.9
Okumura, K.10
-
20
-
-
0028110928
-
Fas and perform pathways as major mechanisms of T cell mediated cytotoxicity
-
Kägi, D., F. Vignaux, B. Ledermann, K. Bürki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perform pathways as major mechanisms of T cell mediated cytotoxicity. Science (Wash. DC). 265:528-530.
-
(1994)
Science (Wash. DC)
, vol.265
, pp. 528-530
-
-
Kägi, D.1
Vignaux, F.2
Ledermann, B.3
Bürki, K.4
Depraetere, V.5
Nagata, S.6
Hengartner, H.7
Golstein, P.8
-
21
-
-
0027937745
-
Cytolytic T cell cytotoxicity is mediated through pertorin and Fas lytic pathways
-
Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T cell cytotoxicity is mediated through pertorin and Fas lytic pathways. Nature (Lond.). 370:650-652.
-
(1994)
Nature (Lond.)
, vol.370
, pp. 650-652
-
-
Lowin, B.1
Hahne, M.2
Mattmann, C.3
Tschopp, J.4
-
24
-
-
0029942839
-
Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity
-
Kägi, D., B. Odermatt, P.S. Ohashi, R.M. Zinkernagel, and H. Hengartner. 1996. Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity. J. Exp. Med. 183:2143-2152.
-
(1996)
J. Exp. Med.
, vol.183
, pp. 2143-2152
-
-
Kägi, D.1
Odermatt, B.2
Ohashi, P.S.3
Zinkernagel, R.M.4
Hengartner, H.5
-
25
-
-
0029582926
-
The roles of perforin- and Fas-dependent cytotoxicity in protection against cytpathic and noncytopathic viruses
-
Kägi, P., P. Seiler, J. Pavlovic, B. Ledermann, K. Bürki, R.M. Zinkernagel, and H. Hengartner. 1995. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytpathic and noncytopathic viruses. Eur. J. Immunol. 25: 3256-3262.
-
(1995)
Eur. J. Immunol.
, vol.25
, pp. 3256-3262
-
-
Kägi, P.1
Seiler, P.2
Pavlovic, J.3
Ledermann, B.4
Bürki, K.5
Zinkernagel, R.M.6
Hengartner, H.7
-
26
-
-
0028916025
-
Acute rejection of vascular heart allografts by perforin deficient mice
-
Schulz, M., H.J. Schuurman, J. Joergensen, C. Steiner, T. Merloo, O. Kägi, H. Hengartner, R.M. Zinkernagel, M. Schreier, K. Bürki, and B. Ledermann. 1995. Acute rejection of vascular heart allografts by perforin deficient mice. Eur. J. Immunol. 25:474-480.
-
(1995)
Eur. J. Immunol.
, vol.25
, pp. 474-480
-
-
Schulz, M.1
Schuurman, H.J.2
Joergensen, J.3
Steiner, C.4
Merloo, T.5
Kägi, O.6
Hengartner, H.7
Zinkernagel, R.M.8
Schreier, M.9
Bürki, K.10
Ledermann, B.11
-
27
-
-
0030046658
-
Cell-mediated cytotoxicity results from, but may not be critical for, primary allograft rejection
-
Walsh, C.M., F. Hayashi, D. Saffran, S. Ju, G. Berke, and W.R. Clark. 1996. Cell-mediated cytotoxicity results from, but may not be critical for, primary allograft rejection. J. Immunol. 156:1436-1441.
-
(1996)
J. Immunol.
, vol.156
, pp. 1436-1441
-
-
Walsh, C.M.1
Hayashi, F.2
Saffran, D.3
Ju, S.4
Berke, G.5
Clark, W.R.6
-
28
-
-
0030050453
-
Cytotoxic T cells deficient in both functional Fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal graft-versus-host disease
-
Braun, M.Y., B. Lowin, L. French, H. Acha-Orbea, and J. Tschopp. 1996. Cytotoxic T cells deficient in both functional Fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal graft-versus-host disease. J. Exp. Med. 183:657-661.
-
(1996)
J. Exp. Med.
, vol.183
, pp. 657-661
-
-
Braun, M.Y.1
Lowin, B.2
French, L.3
Acha-Orbea, H.4
Tschopp, J.5
-
29
-
-
0025906133
-
CD8 is needed for development of cytotoxic T cells but not for helper T cells
-
Fung-Leung, W.P., M.W. Schilham, A. Rahemtulla, T.M. Kündig, M. Vollenweider, J. Potter, W. van Ewijk, and T.W. Mak. 1992. CD8 is needed for development of cytotoxic T cells but not for helper T cells. Cell. 65:443-451.
-
(1992)
Cell
, vol.65
, pp. 443-451
-
-
Fung-Leung, W.P.1
Schilham, M.W.2
Rahemtulla, A.3
Kündig, T.M.4
Vollenweider, M.5
Potter, J.6
Van Ewijk, W.7
Mak, T.W.8
-
30
-
-
0026581936
-
RAG-2 deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement
-
Shinkai, Y., G. Rathbun, K.P. Lam, E.M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A.M. Stall, and F.W. Alt. 1992. RAG-2 deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell. 68:855-864.
-
(1992)
Cell
, vol.68
, pp. 855-864
-
-
Shinkai, Y.1
Rathbun, G.2
Lam, K.P.3
Oltz, E.M.4
Stewart, V.5
Mendelsohn, M.6
Charron, J.7
Datta, M.8
Young, F.9
Stall, A.M.10
Alt, F.W.11
-
31
-
-
0018097239
-
Cytotoxic T cell responses in mice infected with influenza and vaccinia virus vary in magnitude with H-2 genotype
-
Doherty, P.C., W.E. Biddison, J.R. Bennink, and B.B. Knowles. 1978. Cytotoxic T cell responses in mice infected with influenza and vaccinia virus vary in magnitude with H-2 genotype. J. Exp. Med. 148:534-543.
-
(1978)
J. Exp. Med.
, vol.148
, pp. 534-543
-
-
Doherty, P.C.1
Biddison, W.E.2
Bennink, J.R.3
Knowles, B.B.4
-
32
-
-
0022970931
-
N protein is the predominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T cells
-
Puddington, L., M.J. Bevan, and L. Lefrançois. 1986. N protein is the predominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T cells. J. Virol. 60:708-716.
-
(1986)
J. Virol.
, vol.60
, pp. 708-716
-
-
Puddington, L.1
Bevan, M.J.2
Lefrançois, L.3
-
33
-
-
0028942630
-
An adenovirus type 5 early region 1B CTL epitope mediating tumor eradication by CTL clones is downmodulated by an activated ras oncogene
-
Toes, R.E.M., R. Offringa, R.J.J. Blom, R.M.P. Brandt, A.J. van der Eb, C.J.M. Melief, and W.J.M. Kast. 1995. An adenovirus type 5 early region 1B CTL epitope mediating tumor eradication by CTL clones is downmodulated by an activated ras oncogene. J. Immunol. 154:3396-3405.
-
(1995)
J. Immunol.
, vol.154
, pp. 3396-3405
-
-
Toes, R.E.M.1
Offringa, R.2
Blom, R.J.J.3
Brandt, R.M.P.4
Van Der Eb, A.J.5
Melief, C.J.M.6
Kast, W.J.M.7
-
34
-
-
0021723276
-
Therapy with monoclonal antibodies by elimination of T cell subsets in vivo
-
Cobbold, S.P., A. Jayasuriya, A. Nasch, T.D. Prospero, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T cell subsets in vivo. Nature (Lond.). 312: 548-552.
-
(1984)
Nature (Lond.)
, vol.312
, pp. 548-552
-
-
Cobbold, S.P.1
Jayasuriya, A.2
Nasch, A.3
Prospero, T.D.4
Waldmann, H.5
-
35
-
-
0024362683
-
Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors
-
Sheenan, K.C.F., N.H. Ruddle, and R.D. Schreiber. 1989. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J. Immunol. 142:3884-3893.
-
(1989)
J. Immunol.
, vol.142
, pp. 3884-3893
-
-
Sheenan, K.C.F.1
Ruddle, N.H.2
Schreiber, R.D.3
-
36
-
-
0021917922
-
Vaccinia virus recombinants: Expression of VSV genes and protective immunization of mice and cattle
-
Mackett, M., T. Yilma, J.K. Rose, and B. Moss. 1985. Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle. Science (Wash. DC). 227:433-435.
-
(1985)
Science (Wash. DC)
, vol.227
, pp. 433-435
-
-
Mackett, M.1
Yilma, T.2
Rose, J.K.3
Moss, B.4
-
37
-
-
0029881627
-
Different susceptibility of cytotoxic T cells to CD97 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo
-
Ehl, S., U. Hoffmann-Rohrer, S. Nagata, H. Hengartner, and R.M. Zinkernagel. 1996. Different susceptibility of cytotoxic T cells to CD97 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo. J. Immunol. 156: 2357-2360.
-
(1996)
J. Immunol.
, vol.156
, pp. 2357-2360
-
-
Ehl, S.1
Hoffmann-Rohrer, U.2
Nagata, S.3
Hengartner, H.4
Zinkernagel, R.M.5
-
38
-
-
0002046199
-
Lymphocytic choriomeningitis virus
-
Lehmann-Grube, F. 1971. Lymphocytic choriomeningitis virus. Virol. Monogr. 10:1-11.
-
(1971)
Virol. Monogr.
, vol.10
, pp. 1-11
-
-
Lehmann-Grube, F.1
-
39
-
-
0019474323
-
Cytotoxic T cell response against lymphoblasts infected with Moloney (Abelson) murine leukemia virus. Methodological aspects and H-2 requirements
-
Stukart, M.J., A. Vos, and C.J.M. Melief. 1981. Cytotoxic T cell response against lymphoblasts infected with Moloney (Abelson) murine leukemia virus. Methodological aspects and H-2 requirements. Eur. J. Immunol. 11:251-257.
-
(1981)
Eur. J. Immunol.
, vol.11
, pp. 251-257
-
-
Stukart, M.J.1
Vos, A.2
Melief, C.J.M.3
-
40
-
-
0024992268
-
Viral escape by selection of cytotoxic T cell resistant variants in vivo
-
Pircher, H.P., D. Moskophidis, U. Rohrer, K. Bürki, H. Hengartner, and R.M. Zinkernagel. 1990. Viral escape by selection of cytotoxic T cell resistant variants in vivo. Nature (Lond.). 346:629-633.
-
(1990)
Nature (Lond.)
, vol.346
, pp. 629-633
-
-
Pircher, H.P.1
Moskophidis, D.2
Rohrer, U.3
Bürki, K.4
Hengartner, H.5
Zinkernagel, R.M.6
-
41
-
-
0027198148
-
DNA adducts, cell proliferation and papilloma latency time in mouse skin after repeated dermal application of DMBA and TPA
-
Fischer, W.H., P.E. Beland, and W.K. Lutz. 1993. DNA adducts, cell proliferation and papilloma latency time in mouse skin after repeated dermal application of DMBA and TPA. Carcinogenesis. 14:1285-1288.
-
(1993)
Carcinogenesis
, vol.14
, pp. 1285-1288
-
-
Fischer, W.H.1
Beland, P.E.2
Lutz, W.K.3
-
42
-
-
0027229226
-
Nonimmunogenic tumor cells may efficiently restimulate tumor antigen-specific cytotoxic T cells
-
Kündig, T.M., M.F. Bachmann, L. Lefrançois, L. Puddington, H. Hengartner, and R. Zinkernagel. 1993. Nonimmunogenic tumor cells may efficiently restimulate tumor antigen-specific cytotoxic T cells. J. Immunol. 150:4450-4456.
-
(1993)
J. Immunol.
, vol.150
, pp. 4450-4456
-
-
Kündig, T.M.1
Bachmann, M.F.2
Lefrançois, L.3
Puddington, L.4
Hengartner, H.5
Zinkernagel, R.6
-
43
-
-
0028327190
-
Anti-Fas on non-hematopoietic tumors: Levels of Fas/APO-1 and bcl-2 are not predictive for biological responsiveness
-
Owen, S.L., R. Radinsky, E. Kruzel, K. Berry, and S. Yonehara. 1994. Anti-Fas on non-hematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive for biological responsiveness. Cancer Res. 54:1580-1586.
-
(1994)
Cancer Res.
, vol.54
, pp. 1580-1586
-
-
Owen, S.L.1
Radinsky, R.2
Kruzel, E.3
Berry, K.4
Yonehara, S.5
-
44
-
-
70449193189
-
Immunity to methylcholanthrene-induced sarcomas
-
Prehn, R.T., and J.M. Main. 1957. Immunity to methylcholanthrene-induced sarcomas. J. Natl. Cancer Inst. 18: 769-778.
-
(1957)
J. Natl. Cancer Inst.
, vol.18
, pp. 769-778
-
-
Prehn, R.T.1
Main, J.M.2
-
45
-
-
0017581358
-
Selective incorporation of H-2 antigenic determinants into Friend virus particles
-
Bubbers, E.J., and F. Lilly. 1977. Selective incorporation of H-2 antigenic determinants into Friend virus particles. Nature (Lond.). 266:458-459.
-
(1977)
Nature (Lond.)
, vol.266
, pp. 458-459
-
-
Bubbers, E.J.1
Lilly, F.2
-
46
-
-
0018191160
-
Nonrandom inclusion of H-2K and H-2D antigens in Friend virus particles from mice of various strains
-
Bubbers, E.J., S. Chen, and F. Lilly. 1978. Nonrandom inclusion of H-2K and H-2D antigens in Friend virus particles from mice of various strains. J. Exp. Med. 147:340-351.
-
(1978)
J. Exp. Med.
, vol.147
, pp. 340-351
-
-
Bubbers, E.J.1
Chen, S.2
Lilly, F.3
-
47
-
-
0017421226
-
The murin sarcoma virus-induced tumor: Exception or general model in tumor immunology?
-
Levy, J.P., and J.C. Leclerc. 1977. The murin sarcoma virus-induced tumor: exception or general model in tumor immunology? Adv. Cancer Res. 24:1-66.
-
(1977)
Adv. Cancer Res.
, vol.24
, pp. 1-66
-
-
Levy, J.P.1
Leclerc, J.C.2
|